Indian Patent Application (complete specifications), filed on 23.01.2019, Title: “Design and Development of Functioal Mimics of ?-Secretase and their Application in Drug Design against Amyloidoses” . Application No. 201931002772, Inventors: Dr. Bhubaneswar Mandal and Mr. Tanmay Mondal
Indian Patent Application (complete specifications), filed on 14.12.2017, Title: “A NOVEL COUPLING REAGENT FOR ESTERIFICATION, THIOESTERIFICATION, AMIDATION AND PEPTIDE SYNTHESIS” . Application No. 201731045011, Inventors: Dr. Bhubaneswar Mandal, Ms. Jyoti Chandra, Mr. Srinivasa Rao Manne and Mr. Sandip Mondal
Indian patent application (complete specifications), filed on the 9th May, 2017; Title: “A METHOD FOR PREPARTION OF SULPHONATES OF ALCOHOL, OXIME-O-SULPHONATES AND THEIR DERIVATIVES”; Application No. 201731016281; Inventors: Dr. Bhubaneswar Mandal and Ms. Jyoti Chandra. Granted on 31.07.2019, Patent No. 317283
Indian patent application (complete specifications), filed on the 26th May, 2016; Title: TITLE: “?-SHEET BREAKER PEPTIDES FOR DRUG DESIGN AGAINST DIABETES TYPE-2”; Application No. 201631018104; Inventors: Dr. Bhubaneswar Mandal and Mr. Ashim Paul. Granted on 24.03.2021, Patent No. 362950
Indian patent application (complete specifications), filed on the 17th September, 2015; Title: Beta Sheet Breaker Peptides for Anti-Alzheimer Drug Design; Application No. E-2/1727/2015/KOL; Inventors: Dr. Bhubaneswar Mandal and Mr. Ashim Paul. A provisional application was filed on the 26th September, 2014; Application No. 997/KOL/2014
Title: Tailor Made Peptidomimetics Designing Against Human Islet Amyloid Polypeptide (hIAPP) Aggregation: A Therapeutic Approach Associated with Type-2 Diabetes. approved, fund yet to come ; Funding agency: DBT; Amount:
Title: Peptidomimetic/Peptide inhibitor design and synthesis against sEGFR to treat lung cancer -[ 28090 ]; Funding agency: DBT; Amount: ; Status: submitted
Title: Beta breaker di-peptides: development of a novel approach for amyloid disruption, phase II: At the quest of lead; Funding agency: BRNS; Amount: 25 Lakhs; Status: submitted
Title: Effect of naturally occurring as well as synthetic cyclic molecules on inhibition of beta amyloid aggregation in vivo and in vitro; Funding agency: DBT (twinning program); Amount: 72 Lakhs; Status: Ongoing ; Co-Investigator: Dr. Amal Chandra Mondal, JNU, New DelhI
Title: Diptheria toxin derived peptides for possible therapeutic uses; Funding agency: DST; Amount: 47 Lakhs; Status: Ongoing ; PI: Dr. Biplab Bose, BSBE, IITG ; Co-PI: Dr. Bhubaneswar Mandal, CHEM, IITG
Title: Arresting pre fibriller aggregates of Alzheimer’s amyloid by synthetic antibodies; Funding agency: DBT (twinning program); Amount: 56 Lakhs; Status: Completed ; Co-Investigator: Dr. Amal Chandra Mondal, Raja Peary Mohan College, Uttarpara, Hooghly (W.B.)
Title: Beta breaker di-peptides: development of a novel approach for amyloid disruption; Funding agency: BRNS (Young Scientist Research Award); Amount: 17 Lakhs; Status: Completed
Title: A new, cost effective and green improvement of solid phase peptide synthesis; Funding agency: IITG (start up grant); Amount: 5 Lakhs; Status: Completed
Title: Synthesis and biological evaluation of a novel class of multi-target-directed ligands as potential leads against amyloid diseases; Funding agency: DST (FAST TRACK); Amount: 19 Lakhs; Status: Completed